Can-Fite Biopharma Announced It Published An Article In The Experimental And Therapeutic Medicine Journal, "Long-term Complete Response To Namodenoson In Liver Cancer With Child-Pugh B Cirrhosis
Can-Fite Biopharma Announced It Published An Article In The Experimental And Therapeutic Medicine Journal, "Long-term Complete Response To Namodenoson In Liver Cancer With Child-Pugh B Cirrhosis
Can-Fite Biopharma宣布在《实验与治疗医学》杂志上发表了一篇文章，“对Child-Pugh B肝硬化肝癌中的纳莫德诺松的长期全面反应
The Patient Participated In The Phase Ii Liver Cancer Study And Has Been Treated With Namodenoson For >7 Years Under Compassionate Use Program
该患者参与了II期肝癌研究，并根据同情使用计划接受了Namodenoson的治疗超过7年